![Sandeep Laumas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandeep Laumas
Director of Finance/CFO at
INSTIL BIO, INC.
Net worth: 1 M $ as of 30/05/2026
Profile
Sandeep Laumas is the founder of Bearing Circle Capital LP, founded in 2007, serving as Managing Director.
Current jobs include Director at Globavir Biosciences, Inc. since 2015, Independent Director at BioXcel Therapeutics, Inc. since 2017, and Independent Director at Unicycive Therapeutics, Inc. since 2018.
Former jobs include Managing Director at North Sound Capital LLC (Old) from 2003 to 2008, Director at Parkway Holdings Ltd. in 2010, Director at Agilus Diagnostics Ltd. from 2011 to 2012, Director at BioXcel Corp.
from 2013 to 2017, Director at 9 Meters Biopharma, Inc. from 2020 to 2021, Director at Invea Therapeutics, Inc., and Analyst at Balyasny Asset Management LP from 2001 to 2003.
Education includes an undergraduate degree from Cornell University in 1990 and a doctorate from Albany Medical College in 1995.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INSTIL BIO, INC. 2.36% | 12/04/2026 | 159,999 ( 2.36% ) | 1 M $ | 30/05/2026 |
| 13/05/2026 | 10,583 ( 0.04% ) | 78 103 $ | 30/05/2026 | |
| 08/01/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Sandeep Laumas active positions
| Companies | Position | Start |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Director/Board Member | 31/08/2017 |
| UNICYCIVE THERAPEUTICS, INC. | Director/Board Member | 31/12/2017 |
| INSTIL BIO, INC. | Director of Finance/CFO | 31/01/2021 |
Bearing Circle Capital LP | Founder | 31/07/2007 |
Globavir Biosciences, Inc.
 Globavir Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutics and diagnostics for treatment of infectious diseases | Director/Board Member | 31/12/2014 |
Former positions of Sandeep Laumas
| Companies | Position | End |
|---|---|---|
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Director/Board Member | 31/03/2022 |
| 9 METERS BIOPHARMA, INC. | Chief Executive Officer | 29/04/2020 |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions | Director/Board Member | 31/07/2017 |
Agilus Diagnostics Ltd.
 Agilus Diagnostics Ltd. Medical/Nursing ServicesHealth Services Provides diagnostic services | Director/Board Member | 31/12/2011 |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Sandeep Laumas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
North Sound Capital LLC (Old)
 North Sound Capital LLC (Old) Investment ManagersFinance NSC is a multi-cap value hedge fund manager that primarily shorts US stocks without sector restriction. Their research effort is fundamental and makes use of in-house and Wall Street research. Sector weighting is typically tied to the Barra S&P 500 index. | Finance |
Balyasny Asset Management LP
 Balyasny Asset Management LP Investment ManagersFinance BAM aims to deliver consistent, uncorrelated absolute returns in all market environments. The firm manages multi-strategy investment funds which maintain a concentrated private equity portfolio. Their investment advisory services reflect a blend of strategies including fundamental long/short equity, macro & rates, systematic trading and event & credit investing. BAM’s long/short equity and equity trading strategies include (but are not limited to) investments and trading in the following market sectors: Energy, Health Care, Financials, Industrials, Information Technology, Consumer Staples and Consumer Discretionary. | Finance |
Parkway Holdings Ltd.
 Parkway Holdings Ltd. Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agilus Diagnostics Ltd.
Agilus Diagnostics Ltd. Medical/Nursing ServicesHealth Services Provides diagnostic services | Health Services |
Albany Medical College
 Albany Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bearing Circle Capital LP | |
Globavir Biosciences, Inc.
Globavir Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in development of therapeutics and diagnostics for treatment of infectious diseases | Commercial Services |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions | Technology Services |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Unicycive Therapeutics, Inc.
 Unicycive Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs to treat kidney diseases | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Health Technology |
- Stock Market
- Insiders
- Sandeep Laumas
